In recent years GLP-1 medications have surged in popularity, becoming a cornerstone in the management of certain chronic conditions, particularly Type 2 diabetes and obesity. The clinical benefits of these drugs are clear, but they come with a high price tag, raising important questions about cost management and long-term sustainability.

During this webinar we’ll explore GLP-1 medications in depth, providing you with the knowledge you need to make informed decisions about the best ways to incorporate these drugs into your benefits plan. Together we’ll discuss:

• How GLP-1s work, including the scientific principles behind their efficacy
• Practical cost-management strategies to offer these popular medications while maintaining financial health
• Risk assessment and mitigation, providing you with the knowledge to help members safely navigate this rapidly expanding market

Panelists

Stanley Crittenden, M.D., FASN

Chief Medical Officer
Quantum Health

Janice Rosenthal RN

Clinical Consultant
Marsh McLennan Agency

Jordan Counts

Director, Pharmacy Services
Quantum Health